http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101122456-B1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4196
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D271-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D249-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D285-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D285-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D271-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4196
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D285-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D271-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D249-12
filingDate 2004-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2012-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2012-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-101122456-B1
titleOfInvention Non-Nucleoside Reverse Transcriptase Inhibitor I for Treating HIV-Mediated Diseases I
abstract The present invention relates to novel heterocyclic compounds of formula (I) and pharmaceutically acceptable salts and solvates thereof, methods of inhibiting or regulating human immunodeficiency virus (HIV) reverse transcriptase with compounds of formula (I), one or more solvents, carriers or A pharmaceutical composition comprising a compound of formula (I) in admixture with an excipient, and a method for preparing a compound of formula (I):n n n Formula In n n n n n n n Wherein R 1 to R 4 , X 1 and X 2 are as defined herein.n n n The compounds are useful for treating diseases involving HIV and genetically related viruses.
priorityDate 2003-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002275165-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0236576-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468065974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467491808
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467356708

Total number of triples: 26.